Comparison of pregnancy outcomes following intrauterine insemination in young women with decreased versus normal ovarian reserve

Reproductive outcomes of young women <35 years undergoing intrauterine insemination with diminished ovarian reserve were similar to normal controls while adjusting for body mass index, dominant follicle number, and treatment.

Volume 113, Issue 4, Pages 788–796.e4


Ashley W. Tiegs, M.D., Li Sun, Ph.D., Richard T. Scott Jr., M.D., Linnea R. Goodman, M.D.



To evaluate pregnancy outcomes following intrauterine insemination (IUI) in young women with low ovarian reserve compared to age-matched controls.


Retrospective cohort


Single infertility center (July 2001–August 2018)


Patients <35 years of age undergoing at least one IUI cycle with a documented serum anti-Müllerian hormone (AMH) level, patent fallopian tubes, and total motile sperm count of ≥10 million at the time of IUI.



Main Outcome Measure(s)

The primary outcome was the presence of a positive serum hCG pregnancy test (>2 mIU/mL) obtained 2 weeks after the IUI procedure. Secondary outcomes included the incidence of live birth, biochemical loss, clinical miscarriage, and ectopic pregnancy. Additionally, cumulative reproductive outcomes including up to seven IUI cycles were calculated and compared between groups.


A post-hoc power calculation demonstrated that the study sample size yielded >80% power to detect a 7% difference between groups in the primary outcome. There were 3019 patients included: 370 with AMH <1.0 ng/mL and 2649 with AMH ≥1.0 ng/mL. When adjusting for IUI treatment strategy, number of dominant follicles at time of IUI and body mass index, no difference in per-cycle or cumulative reproductive outcomes was identified between patients with low AMH (<1.0 ng/mL) and normal AMH (≥1.0 ng/mL). Analyses by treatment strategy also showed no difference in reproductive outcomes.


Young patients (<35 years of age) with diminished ovarian reserve conceived as often and had per-cycle and cumulative pregnancy outcomes similar to those of age-matched controls after IUI, regardless of treatment strategy.

Read the full text here.